Clinical significance of pleiotropic effects of statins: lipid reduction and beyond

J Auer, R Berent, T Weber… - Current medicinal …, 2002 - ingentaconnect.com
Statins significantly reduce cardiovascular-related morbidity and mortality in patients with
and without coronary artery disease. The potential of this drug class has yet to be fully …

Common Variants of HMGCR, CETP, APOAI, ABCB1, CYP3A4, and CYP7A1 Genes as Predictors of Lipid-Lowering Response to Atorvastatin Therapy

A Poduri, M Khullar, A Bahl, BS Sehrawat… - DNA and cell …, 2010 - liebertpub.com
There is interindividual variation in lipid-lowering response to statins. The objective of this
study was to investigate whether common variation in genes involved in lipid and statin …

[HTML][HTML] Targeting intracellular cholesterol is a novel therapeutic strategy for cancer treatment

CC Mandal, MM Rahman - Journal of cancer science & therapy, 2014 - ncbi.nlm.nih.gov
Substantial data from cell culture and animal studies evidence the preventive effect of
statins, cholesterol lowering-drugs, in regulation of cancer cell proliferation and metastasis …

Pharmacogenetic study of statin therapy and cholesterol reduction

DI Chasman, D Posada, L Subrahmanyan, NR Cook… - Jama, 2004 - jamanetwork.com
ContextPolymorphisms in genes involved in cholesterol synthesis, absorption, and transport
may affect statin efficacy. ObjectiveTo evaluate systematically whether genetic variation …

Pleiotropic effects of statin therapy: molecular mechanisms and clinical results

CY Wang, PY Liu, JK Liao - Trends in molecular medicine, 2008 - cell.com
Statins inhibit the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase,
which is required for cholesterol biosynthesis, and are beneficial in the primary and …

Pharmacogenomics of statin therapy: any new insights in efficacy or safety?

JC Hopewell, C Reith, J Armitage - Current opinion in lipidology, 2014 - journals.lww.com
Pharmacogenomics of statin therapy: any new insights in effi... : Current Opinion in
Lipidology Pharmacogenomics of statin therapy: any new insights in efficacy or safety …

[HTML][HTML] Simvastatin may induce insulin resistance through a novel fatty acid mediated cholesterol independent mechanism

V Kain, B Kapadia, P Misra, U Saxena - Scientific reports, 2015 - nature.com
Statins are a class of oral drugs that are widely used for treatment of hypercholesterolemia.
Recent clinical data suggest that chronic use of these drugs increases the frequency of new …

HMGCR and ApoE mutations may cause different responses to lipid lowering statin therapy

D Kirac, E Bayam, M Dagdelen… - Cellular and …, 2017 - mail.cellmolbiol.org
Coronary artery disease (CAD) and its complications are the major causes of death in the
world. Although statins have been used to lower lipid levels in CAD patients, this goal can …

[HTML][HTML] Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study

R Kaddurah-Daouk, RA Baillie, H Zhu, ZB Zeng… - Metabolomics, 2010 - Springer
Statins are commonly used for reducing cardiovascular disease risk but therapeutic benefit
and reductions in levels of low-density lipoprotein cholesterol (LDL-C) vary among …

Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex

LN Johnson-Anuna, GP Eckert, JH Keller… - … of Pharmacology and …, 2005 - ASPET
Statins have been reported to lower the risk of developing Alzheimer's disease; however, the
mechanism of this potentially important neuroprotective action is not understood. Lowering …